Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Chazot

Showing results (121-130 of 147) with videos related to

Pageof 15
Sort By:
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
PET and plasma pharmacokinetic studies after bolus intravenous administration of [11C]melatonin in humansD Le Bars, P Thivolle, P A Vitte, et al.
Revue Neurologique|December 1, 1995
[Progressive lupus dementia. 2 cases with or without antiphospholipid antibodies]C Robin, P M Gonnaud, I Durieu, et al.
Human Molecular Genetics|December 1, 1993
The major peripheral myelin protein zero gene: structure and localization in the cluster of Fc gamma receptor genes on human chromosome 1q21.3-q23D Pham-Dinh, Y Fourbil, F Blanquet, et al.
La Revue De Medecine Interne|December 31, 2002
[Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (Melas) associated with a Fahr disease and cerebellar calcifications]S Younes-Mhenni, S Thobois, N Streichenberger, et al.
Human Mutation|January 1, 1996
Charcot-Marie-Tooth type 1B neuropathy: a mutation at the single glycosylation site in the major peripheral myelin glycoprotein PoF Blanquet-Grossard, D Pham-Dinh, A Dautigny, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 25, 2002
Glial toxicity in urine and multiple sclerosisC Malcus-Vocanson, P Giraud, F Micoud, et al.
European Neurology|January 1, 1997
Clinical and electrophysiological phenotype of a homozygously duplicated Charcot-Marie-Tooth (type 1A) diseaseF G Sturtz, P Latour, Y Mocquard, et al.
Human Mutation|January 1, 1995
Mutations in the myelin protein zero gene associated with Charcot-Marie-Tooth disease type 1BP Latour, F Blanquet, E Nelis, et al.
Neurology|February 1, 1981
Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical ameliorationG Tell, P Böhlen, P J Schechter, et al.
European Neurology|December 5, 2002
The timing of antiparkinsonian treatment reduction after subthalamic nucleus stimulationS Thobois, S Corvaisier, P Mertens, et al.
Pageof 15

Showing results (121-130 of 147) with videos related to

Sort By:
Pageof 15
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
PET and plasma pharmacokinetic studies after bolus intravenous administration of [11C]melatonin in humansD Le Bars, P Thivolle, P A Vitte, et al.
Revue Neurologique|December 1, 1995
[Progressive lupus dementia. 2 cases with or without antiphospholipid antibodies]C Robin, P M Gonnaud, I Durieu, et al.
Human Molecular Genetics|December 1, 1993
The major peripheral myelin protein zero gene: structure and localization in the cluster of Fc gamma receptor genes on human chromosome 1q21.3-q23D Pham-Dinh, Y Fourbil, F Blanquet, et al.
La Revue De Medecine Interne|December 31, 2002
[Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (Melas) associated with a Fahr disease and cerebellar calcifications]S Younes-Mhenni, S Thobois, N Streichenberger, et al.
Human Mutation|January 1, 1996
Charcot-Marie-Tooth type 1B neuropathy: a mutation at the single glycosylation site in the major peripheral myelin glycoprotein PoF Blanquet-Grossard, D Pham-Dinh, A Dautigny, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 25, 2002
Glial toxicity in urine and multiple sclerosisC Malcus-Vocanson, P Giraud, F Micoud, et al.
European Neurology|January 1, 1997
Clinical and electrophysiological phenotype of a homozygously duplicated Charcot-Marie-Tooth (type 1A) diseaseF G Sturtz, P Latour, Y Mocquard, et al.
Human Mutation|January 1, 1995
Mutations in the myelin protein zero gene associated with Charcot-Marie-Tooth disease type 1BP Latour, F Blanquet, E Nelis, et al.
Neurology|February 1, 1981
Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical ameliorationG Tell, P Böhlen, P J Schechter, et al.
European Neurology|December 5, 2002
The timing of antiparkinsonian treatment reduction after subthalamic nucleus stimulationS Thobois, S Corvaisier, P Mertens, et al.
Pageof 15